Infection Risk With Biologic Therapy in Patients With Inflammatory Bowel Disease

被引：29

作者：

Hindryckx, Pieter ^{[1
]}

Novak, Gregor ^{[2
]}

Bonovas, Stefanos ^{[3
]}

Peyrin-Biroulet, Laurent ^{[4
]}

Danese, Silvio ^{[3
,5
]}

机构：

[1] Univ Ghent, Dept Gastroenterol, Ghent, Belgium

[2] Univ Ljubljana, Dept Gastroenterol, Med Ctr, Ljubljana, Slovenia

[3] Humanitas Clin & Res Ctr, IBD Ctr, Dept Gastroenterol, Milan, Italy

[4] Lorraine Univ, Univ Hosp Nancy, Inserm, U954, Vandoeuvre Les Nancy, France

[5] Humanitas Univ, Dept Biomed Sci, Milan, Italy

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2017年 / 102卷 / 04期

关键词：

NONSTEROIDAL ANTIINFLAMMATORY DRUGS; EVENT TRIAL TARGET; CARDIOVASCULAR SAFETY; CENTRAL SENSITIZATION; CHRONIC PAIN; CYCLOOXYGENASE ISOFORMS; OSTEOARTHRITIS PAIN; ARTHRITIS RESEARCH; KNEE REPLACEMENT; COX-2; INHIBITION;

D O I：

10.1002/cpt.791

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The development of biologic drugs revolutionized the management of inflammatory bowel diseases: Crohn's disease and ulcerative colitis. However, while their efficacy has been well established, it remains uncertain to what extent biologic treatments may be associated with important safety risks, such as serious infections, opportunistic infections, or tuberculosis reactivation. Herein, we review and discuss the current evidence on the infection risk associated with biologic therapy in patients with inflammatory bowel disease (IBD).

引用

页码：633 / 641

页数：9

共 50 条

[21] Inflammatory bowel disease surgery in the biologic therapy era
Strong, Scott A.
CURRENT OPINION IN GASTROENTEROLOGY, 2012, 28 (04) : 349 - 353
[22] The Role of Dual Biologic Therapy in Inflammatory Bowel Disease
Molly, Stone
Margaret, Morrison
Erin, Forster
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S20 - S20
[23] Biologic therapy for inflammatory bowel disease comes of age
Hanauer S.B.
Current Gastroenterology Reports, 2007, 9 (6) : 485 - 488
[24] Biologic therapy for inflammatory bowel disease comes of age
Stephen B. Hanauer
Current Gastroenterology Reports, 2008, 10 (6)
[25] The Role of Early Biologic Therapy in Inflammatory Bowel Disease
Berg, Dana Rachel
Colombel, Jean-Frederic
Ungaro, Ryan
INFLAMMATORY BOWEL DISEASES, 2019, 25 (12) : 1896 - 1905
[26] Leucocytapheresis for inflammatory bowel disease in the era of biologic therapy
Hanai, Hiroyuki
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2008, 20 (07) : 596 - 600
[27] The Role of Biologic Therapy in Inflammatory Bowel Disease - Preface
Lichtenstein, Gary R.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2006, 35 (04) : XIII - XIV
[28] Dual biologic therapy in pediatric Inflammatory Bowel Disease
Abbas, R.
Ibrahim, N.
Elawad, M.
Al-Mudahka, F.
Abdelrhman, H.
Akobeng, A. K.
JOURNAL OF CROHNS & COLITIS, 2023, 17 : 747 - 747
[29] Evolutionary biologic therapy for inflammatory bowel disease.
Hanauer S.B.
Current Gastroenterology Reports, 1999, 1 (6) : 467 - 469
[30] A COMPARATIVE ANALYSIS OF CLOSTRIDIOIDES DIFFICILE INFECTION AMONG PATIENTS ON BIOLOGIC AND SMALL MOLECULE THERAPY FOR INFLAMMATORY BOWEL DISEASE
Gogokhia, Lasha
Cornet, Nicole
Bryan, John
Crawford, Carl V.
Lukin, Dana J.
GASTROENTEROLOGY, 2023, 164 (06) : S646 - S646

← 1 2 3 4 5 →